BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23858585)

  • 1. [Botulinum toxin in the treatment of cerebral palsy--case conference].
    Nezu A; Iai M
    No To Hattatsu; 2010 May; 42(3):230-2. PubMed ID: 23858585
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
    Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
    Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin in the treatment of cerebral palsy: case conference].
    Nezu A; Adachi M
    No To Hattatsu; 2012 May; 44(3):225-7. PubMed ID: 22712224
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
    Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
    J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treated patients in survey: High satisfaction with botulinum toxin in palmar hyperhidrosis].
    Deebaj R; Emtestam L; Lundeberg L; Brandin Samuelsson K; Girnita A
    Lakartidningen; 2015 Jan; 112():. PubMed ID: 25625725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
    J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with botulinum toxin in the treatment of cerebral palsy.
    Arens LJ; Leary PM; Goldschmidt RB
    S Afr Med J; 1997 Aug; 87(8):1001-3. PubMed ID: 9323408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
    Langdon K; Blair E; Davidson SA; Valentine J
    Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
    [No Abstract]   [Full Text] [Related]  

  • 9. Constipation as an adverse event after botulinum toxin A treatment in children with cerebral palsy.
    Vles GF; Vles JSh
    Dev Med Child Neurol; 2010 Oct; 52(10):972; author reply 974. PubMed ID: 20561010
    [No Abstract]   [Full Text] [Related]  

  • 10. Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy.
    Wong V; Ng A; Sit P
    J Child Neurol; 2002 Feb; 17(2):138-42. PubMed ID: 11952075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?
    Bradley LJ; Huntley JS
    Arch Dis Child; 2014 Apr; 99(4):392-4. PubMed ID: 24626322
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum toxin for the treatment of menopausal hot flushes: a pilot study.
    Odo ME; Odo LM; Farias RV; Primavera RA; Leão L; Cucé LC; Juliano Y
    Dermatol Surg; 2011 Nov; 37(11):1579-83. PubMed ID: 21790852
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
    Lee JH; Sung IY; Yoo JY; Park EH; Park SR
    J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review.
    Gormley ME; Gaebler-Spira D; Delgado MR
    J Child Neurol; 2001 Feb; 16(2):113-8. PubMed ID: 11292216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Hailey-Hailey disease with botulinum toxin.
    Charlton OA; Stewart TJ; Rosen RH
    Australas J Dermatol; 2018 Aug; 59(3):229-231. PubMed ID: 29044476
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
    Dai AI; Aksoy SN; Demiryürek AT
    J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute sialadenitis secondary to submandibular calculi after botulinum neurotoxin injection for sialorrhea in a child with cerebral palsy.
    Yuan M; Shelton J
    Am J Phys Med Rehabil; 2011 Dec; 90(12):1064-7. PubMed ID: 22019967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review.
    Edgar TS
    J Child Neurol; 2001 Jan; 16(1):37-46. PubMed ID: 11225955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin treatment in children].
    Sätilä H; Vähäsarja V; Paavilainen P
    Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.